Immunological characterization and functional importance of human heart mast cells

Immunopharmacology

Volumn 31, Issue 1, 1995, Pages 1-18

  Marone, Gianni ^a   de Crescenzo, Gennaro ^a   Adt, Monika ^b   Patella, Vincenzo ^a   Arbustini, Eloisa ^c   Genovese, Arturo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Atherosclerosis; Chymase; Heart; Histamine; Leukotriene; Mast cells; Myocarditis; Tryptase

Indexed keywords

CALCIMYCIN; CALCIUM IONOPHORE; COMPLEMENT COMPONENT C5A; COMPOUND 48-80; CONTRAST MEDIUM; DOXORUBICIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; MAITOTOXIN; MORPHINE; PROTAMINE; RECOMBINANT COMPLEMENT COMPONENT C5A; SUBSTANCE P; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL ISOLATION; ELECTRON MICROSCOPY; HEART; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNITY; LUNG PARENCHYMA; MAST CELL; MEDIATOR; MYOCARDITIS; PRIORITY JOURNAL; REVIEW; SKIN; TISSUE DISTRIBUTION;

ANAPHYLAXIS; ARTERIOSCLEROSIS; CARDIOMYOPATHY, RESTRICTIVE; HUMAN; INFLAMMATION MEDIATORS; MAST CELLS; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; NEOVASCULARIZATION, PATHOLOGIC; SERINE ENDOPEPTIDASES; SUPPORT, NON-U.S. GOV'T;

EID: 0028879293     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/0162-3109(95)00037-3     Document Type: Review

References (137)

1. Immunologic characterization of human heart mast cells
2. Demonstration of IgE-sensitized mast cells in human heart and kidney
3. Mast cell heparin stimulates migration of capillary endothelial cells in vitro
4. Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin
5. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells
6. Human skin mast cells: their dispersion, purification, and secretory characterization
7. Cellular immunity to Trypanosoma cruzi is mediated by helper T cells (CD4+)
8. Electrocardiogram of patient in anaphylactic shock
9. A short history of the mast cell
10. Electrocardiographic changes during human anaphylaxis
11. Interleukin 4 is localized to and released by human mast cells
12. Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid
13. The heart as a target organ in systemic allergic reactions
14. The human recombinant c-kit receptor ligand rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils
15. Mast cells and susceptibility to experimental atherosclerosis
16. Cardiac levels of norepinephrine dopamine, serotonon and histamine in Chagas' disease
17. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
18. IgE and cardiovascular disease. Results from a population-based study
19. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects
20. Cardiac anaphylaxis. Complement activation as an amplification system
21. Cardiac dysfunction caused by recombinant human C5a anaphylatoxin: mediation by histamine, adenosine and cyclooxygenase arachidonate metabolites
22. Characterization of the antiinflammatory effect of, FK-506 on human mast cells
23. Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma
24. Modulation of human lung mast cell function by the c-kit receptor ligand
25. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases
26. Tumor growth and angiogenesis in wild type and mast cell deficient mice
27. Immunoglobulin E-mediated degranulation of isolated human lung mast cells
28. Mast-cell degranulation in human hearts
29. Histamine and chondroitin sulphate E proteoglycans released by cultured human colonic mucosa. indication for possible presence of E mast cells
30. Eosinophilic myocarditis: a role for mast cells?
31. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic and therapeutic considerations
32. The Mast-cell System
33. Angiogenesis and inflammation in Gallin JI, Goldstein IM; Snyderman R
34. Increased adventitial mast cells in a patient with coronary spasm
35. Enhancements of human intestinal mast cell mediator release in active ulcerative colitis
36. New concepts about the mast cell
37. Cardiac and renal mast cells: morphology, distribution, fixation and staining properties in the guinea pig and preliminary comparison with human
38. In vitro activation of complement by isolated human heart subcellular membranes
39. Mast cells in hemangiomas and vascular malformations
40. A basophil-activating factor from human T lymphocytes
41. Very low density lipoproteins (VLDL) trigger the release of histamine from human basophils
42. Mast cells as a source of both preformed and immunologically inducible, TNF-α/cachectin
43. Cardiac dysfunction caused by purified human C3a anaphylatoxin
44. Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin
45. 2 on cardiac contractility: a negative inotropism secondary to coronary vasoconstriction conceals a primary positive inotropic action
46. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria
47. Cardiac mast cells in myocardial diseases (in Japanese)
48. Über das erste Auftreten der Mastzellen in einigen Geweben und Organen bei Homoembryonen mit Berücksichtigung der Zunahme dieser Zellen während der Embryonalentwicklung
49. Two types of human mast cells that have distinct neutral protease compositions
50. Role of cardiac mast cells in complement C5a-induced myocardial ischemia
51. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture
52. Mast cells of two types differing in neutral protease composition in the human aortic intima
53. Coronary arteries of cardiac patients are hyperactive and contain stores of amines: a mechanism for coronary spasm
54. Neovascularization and coronary atherosclerotic plaque: cinematographic localization and quantitative histologic analysis
55. Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders
56. + bone marrow progenitor cells
57. Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo
58. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy
59. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro
60. Stimulation of mast cells leads to cholesterol accumulation in macrophages in vitro by a mast cell granule-mediated uptake of low density lipoprotein
61. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis
62. Levels of IgE in the serum of patients with coronary arterial disease
63. The mast cell: a potential link between inflammation and cellular cholesterol deposition in atherogenesis
64. Role of mast cells in atherosclerosis
65. Detection of the terminal complement complex in patient plasma following acute myocardial infarction
66. Chagas' disease: a clinical, epidemiological, and pathological study
67. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity
68. The arrhythmogenic actions of histamine on human atrial fibers
69. Myocardial mast cells in systemic sclerosis. A report of three fatal cases
70. Soluble heparin proteoglycans released from stimulate mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis
71. Inhibition of copper-mediated oxidation of low density lipoproteins by rat serosal mast cells: a novel cellular protective mechanism involving proteolysis of the substrate under oxidative stress
72. Mast cell granules cause proliferation of human microvascular endothelial cells
73. Chemical mediators and the human heart
74. IgE-mediated activation of human heart in vitro
75. Cardiovascular and Metabolic effects of peptide leukotrienes in man
76. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells
77. Pathophysiology of human basophils and mast cells in allergic disorders
78. Human basophils and mast cells
79. Human basophils and mast cells
80. Human heart mast cells in anaphylaxis and cardiovascular disease
81. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology
82. Collagen characterization and cell transformation in human atherosclerosis
83. Mast cells and their relationship to endothelial surfaces
84. Isolation and characterization of heparin from human lung
85. Biochemical and functional characterization of proteoglycans isolated from basophils of patients with chronic myelogenous leukemia
86. Human mast cells produce IL-8
87. Alteration of collagen phenotypes in ischemic cardiomyopathy
88. Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells
89. Protein L. a bacterial Ig-binding protein that activates human basophils and mast cells
90. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells
91. Heparin: studies on human skin mast cells and basophils
92. Human heart mast cells. Isolation purification, ultrastructure, and immunologic characterization
93. Human heart mast cells: a definitive case of mast cell heterogeneity
94. Immunologic and non-immunologic release of histamine and tryptase from human heart mast cells
95. Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy
96. Mast cells in the coronary arteries
97. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction
98. Complement localization and mediation of ischemic injury in baboon myocardium
99. Mast cells in the circulatory system of man
100. Peri-arterial mast cells in coronary atheroma and thrombosis
101. In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi
102. A study of changes in the number of mast cells in the human arterial wall during the stages of development of atherosclerosis
103. Cardiac growth maturation and aging
104. Protamine inhibits capillary formation in growing rat hearts
105. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo
106. Mast cell tryptase is a mitogen for cultured fibroblasts
107. Growth in methylcellulose of human mast cells in hematopoietic colonies stimulated by steel factor, a c-kit ligand
108. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium
109. TC type of human mast cell
110. Human lung macrophages induce histamine release from basophils and mast cells
111. Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release
112. Acid hydrolases and tryptase from secretory granules of dispersed human lung mast cells
113. Cells association of complex of chymase, heparin proteoglycan and protein after degranulation by rat mast cells
114. Regulation of tryptase from human lung mast cells by heparin
115. Quantitation of histamine, tryptase and chymase in dispersed human T and, TC mast cells
116. Dermal mast cells degranulation in systemic sclerosis
117. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart
118. Physiologic manifestations of human anaphylaxis
119. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release
120. Anti-inflammatory effect of cyclosporin A on human skin mast cells
121. Heterogeneity of mediator release from human basophils and mast cells induced by contrast media (CM)
122. Mast cells and basophils in adverse reactions to drugs used during general anesthesia
123. Mouse 3T3 fibroblasts induce rat basophilic leukemia (RBL-2H3) cells to acquire responsiveness to compound 48/80
124. Serum immunoglobulin E response to myocardial infarction
125. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease
126. Mast cell heterogeneity: evidence that mast cells isolated from various connective tissue locations in the rat display markedly graded phenotypes
127. Protamine is an inhibitor of angiogenesis
128. Identification of chondroitin sulfate E in human lung mast cells
129. The cell population of aortic fatty streaks in african green monkeys with special reference to granulocytic cells
130. The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype
131. Identification of highly specific chymase as the major angiotensin II.-forming enzyme in the human heart
132. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit ligand in long-term culture
133. Cardiovascular effects of histamine infusion in man
134. 1 receptor on coronary hemodynamics in man
135. Cardiovascular effects of histamine and sulfidopeptide leukotrienes
136. Human dermal mast cells contain and release tumor necrosis factor a, which induces endothelial leukocyte adhesion molecule 1
137. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis